These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 32917416)
1. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran. Lankarani KB; Honarvar B; Molavi Vardanjani H; Kharmandar A; Gouya MM; Zahraei SM; Baneshi MR; Ali-Akbarpour M; Kazemi M; Seif M; Fard SAZ; Emami A Vaccine; 2020 Oct; 38(45):7100-7107. PubMed ID: 32917416 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of hepatitis A virus infection among schoolchildren and adolescents in Kaduna, Nigeria. Afegbua SL; Bugaje MA; Ahmad AA Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):627-30. PubMed ID: 23959003 [TBL] [Abstract][Full Text] [Related]
3. Epidemiologic patterns of hepatitis A infection during the pre-vaccination era: A population-based survey in Tunisia in 2015. Saffar F; Sellaoui F; Hechaichi A; Chelly S; Bouguerra H; Cherif A; Talmoudi K; Ben Hadj M; Bahrini A; Letaief H; Bahri O; Chahed MK; Bouafif Ép Ben Alaya N Int J Infect Dis; 2022 Apr; 117():162-168. PubMed ID: 35007750 [TBL] [Abstract][Full Text] [Related]
5. Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017. Wang H; Gao P; Chen W; Bai S; Lv M; Ji W; Pang X; Wu J Hum Vaccin Immunother; 2019; 15(2):420-425. PubMed ID: 30260275 [TBL] [Abstract][Full Text] [Related]
6. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea. Chung SJ; Kim TY; Kim SM; Roh M; Yu MY; Lee JH; Oh C; Lee EY; Lee S; Jeon YC; Yoo KS; Sohn JH Clin Mol Hepatol; 2014 Jun; 20(2):162-7. PubMed ID: 25032182 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Hoseini SG; Kelishadi R; Ataei B; Yaran M; Motlagh ME; Ardalan G; Tajadini MH; Mostafavi SN Epidemiol Infect; 2016 Jan; 144(2):291-6. PubMed ID: 26083105 [TBL] [Abstract][Full Text] [Related]
8. Modeling the hepatitis A epidemiological transition in Brazil and Mexico. Van Effelterre T; Guignard A; Marano C; Rojas R; Jacobsen KH Hum Vaccin Immunother; 2017 Aug; 13(8):1942-1951. PubMed ID: 28481680 [TBL] [Abstract][Full Text] [Related]
9. Changes in hepatitis A virus (HAV) seroprevalence in medical students in Bangkok, Thailand, from 1981 to 2016. Sintusek P; Sa-Nguanmoo P; Posuwan N; Jaroonvanichkul V; Vorayingyong A; Poovorawan Y BMC Res Notes; 2018 Sep; 11(1):640. PubMed ID: 30176927 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis A infection in patients with chronic viral liver disease: a cross-sectional study in Jahrom, Iran. Ahmadi Vasmehjani A; Javeshghani D; Baharlou R; Shayestehpour M; Mousavinasab SD; Joharinia N; Enderami SE Epidemiol Infect; 2015 Feb; 143(3):534-9. PubMed ID: 24742346 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines. Carlos JC; Quinones VMT; Adversario MPL; Nailes JM; Songco JC; Garcia DR; Cacayorin MG; Cero MPV; Benedicto-Delfin MPA; Blanco MCC; Natividad NS; Bernabe JD; Chacon HCT; Ascue RAC; Paggao JNK; Comendador LOP; Hernandez-Suarez G; Guzman-Holst A Infect Dis Ther; 2024 May; 13(5):1019-1035. PubMed ID: 38578515 [TBL] [Abstract][Full Text] [Related]
12. Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. Alian S; Ajami A; Ghasemian R; Yadegarinia D East Mediterr Health J; 2011 Oct; 17(10):754-8. PubMed ID: 22256409 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis A among Thai population residing near Myanmar border. Rianthavorn P; Fakthongyoo A; Yamsut S; Theamboonlers A; Poovorawan Y J Health Popul Nutr; 2011 Apr; 29(2):174-7. PubMed ID: 21608427 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine. Dhawan PS; Shah SS; Alvares JF; Kher A; Shankaran ; Kandoth PW; Sheth PN; Kamath H; Kamath A; Koppikar GV; Kalro RH Indian J Gastroenterol; 1998 Jan; 17(1):16-8. PubMed ID: 9465507 [TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Sofian M; Aghakhani A; Farazi AA; Banifazl M; Etemadi G; Azad-Armaki S; Ziazarifi A; Abhari Z; Eslamifar A; Khadem-Sadegh A; Izadi N; Ramezani A Travel Med Infect Dis; 2010 May; 8(3):176-9. PubMed ID: 20541138 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey. Özden HT Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):333-7. PubMed ID: 26703930 [TBL] [Abstract][Full Text] [Related]
18. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea]. Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine. Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833 [TBL] [Abstract][Full Text] [Related]
20. Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009. Kim KA; Lee A; Ki M; Jeong SH PLoS One; 2017; 12(1):e0170432. PubMed ID: 28099530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]